23/05/2026
Highlights from Wednesday evening’s rooftop panel and mixer in Manhattan’s Union Square, where advocates for the Psychedelic-Assisted Psychotherapy movement came together to explore what responsible delivery of psychedelic therapy can and should look like as the field moves closer to broader adoption — particularly in light of the recent executive order advancing psychedelic research.
A huge thank you to our panelists for offering their bold perspectives to our community on the infrastructure required to bring these treatments forward safely: rigorous protocols, a strong therapeutic alliance, clinician education, local advocacy, and delivery models that can, in words echoed throughout the evening, “move at the speed of trust.”
At Journey Clinical, our mission has always been to expand safe, equitable access to Psychedelic-Assisted Psychotherapy. Today, with the largest network of PAP providers in the U.S. delivering KAP and Spravato through a collaborative care model — supported by insurance coverage, drug development partnerships, and the clinical infrastructure for both the medical and psychotherapeutic arms of treatment — we are proud to serve as America’s gateway to psychedelics, with safety and responsible care at the heart of our model.
Panelists:
Myriam Barthes, CEO & Co-Founder & Jonathan Sabbagh, Co-Founder & Executive Chairman,
Greg Kubin, Co-Founder & Partner,
Dr. Rachel Yehuda, Icahn School of Medicine at Mount Sinai
Rebecca Love, LCSW, Founder of Plant Parenthood and Journey Clinical KAP Provider
Production Crew:
Photos:
PR:
Producers:
Catering:
Bar:
Live Guitar: .tones
AV:
And to everyone who joined us — thank you for being a part of this moment. We hope you’ll continue to stay involved with our community events and online programming. 💜 For those who couldn’t make it, a recording of the panel will be posted shortly and some exciting ways to get involved to celebrate World Psychedelics Day on June 20th from wherever you are. 🎉